Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Total Knee Replacement: early-phase trial registry

3 of 10 indexed Total Knee Replacement trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Total Knee Replacement: 10 US clinical trials tracked, 3 recruiting.

Total Knee Replacement is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 2 of these trials.

Enrollment posture brief

Registry condition total-knee-replacement

OPEN 3 | RECR 30% | LATE 1 | EARLY 3 | RANK #1724 | SPON 2

Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Total Knee Replacement (this)30%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Total Knee Replacement

Total Knee Replacement lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Total Knee Replacement on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Total Knee Replacement is recruiting below its size-band peers.

    3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Total Knee Replacement research.

    Yale University accounts for 2 of 10 trials (20%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Total Knee Replacement enrolment sits around 130 participants.

    Median target enrolment is 130 among the 10 trials that report a genuine target (sentinel values excluded). 5 of those (50%) plan for fewer than 100 participants.

  4. Total Knee Replacement research is mostly interventional.

    8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23Phase 41

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 4 1

Named interventions

Most-linked intervention names on Total Knee Replacement records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate Drug
2 trials
Bupivacaine-Liposomal Bupivacaine Drug
2 trials
Mindfulness Meditation Intervention Other
1 trials
GAPFLEX Device
1 trials
N2Vac Polyethylene Device
1 trials
X3 Polyethylene Device
1 trials
pre-mixed tobramycin Device
1 trials
hand mixed tobramycin Drug
1 trials

US sites by state

Facility locations filed on Total Knee Replacement trials. A trial with sites in several states counts in each.

New York 2 trials
Minnesota 2 trials
Kansas 2 trials
Connecticut 2 trials
Texas 1 trials
Nebraska 1 trials
North Carolina 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Total Knee Replacement page

10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Total Knee Replacement trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Yale University sponsors the most Total Knee Replacement trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Total Knee Replacement condition card totals 10 registered trials; most-linked intervention Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.